The Post-pandemic Health Industry: Tech Is Poised to Play a Much Bigger Role

  • A new wave of consolidations in the healthcare industry to come.
  • Technological solutions are already changing the ways patients are treated, and how new drugs are developed.
  • The adoption of digital technologies in the health and life sciences sector is not going to be rapid.

As the Covid-19 vaccines are starting to roll out across several countries, the global health industry is still trying to overcome the disruptions caused by the coronavirus. Though this market’s technological segment has been slowly growing in the past, the pandemic-caused limitations have pushed the innovations to the fore. Digital tools, like AI or secure video conferencing, have become critical to tackle the challenges of the ‘new normal.’

Pharmaceutical and life sciences companies have found out that several of their activities can be done remotely, thus cutting costs. 38% of industry executives expect that more than a quarter of their clinical trials will be virtual by 2025, PwC’s Health Research Institute survey shows.

During the M&A Community webinar, we discussed how the next normal could present itself with emerging opportunities, challenges, and new use cases in the US, and globally.

Tech Advancements to Change Patient Treatment

2021 is going to be a fantastic year for the health industry, believes Dr. Gary Epler, Associate Professor of Medicine at the Harvard Medical School, and Managing Director at Gracewater Capital. He explains that Covid has caused two significant changes in the health sphere.

  1. Some companies are flourishing, showing better results than ever before. Thus, these businesses will be looking for acquisition opportunities. Others, facing disruptions in supply chains or customer base, will be looking to be acquired.
  2. Healthcare development: New molecular diagnostic tools, enhancements of MRI imagery, etc. With genome-based biotech, Dr. Epler stresses that the number of treatment options is larger than ever.

In terms of M&A, our panelist lists some of the most lucrative industries to look at.

  • MedTech. ‘This is the place for big players, namely GE Healthcare, Medtronic, and several others. They are looking to increase the size of their R&D departments to develop new products and services,’ Dr. Epler explains.
  • Digital Health. Simply put, this industry deals with the digitalization of any process in healthcare. It started with electronic medical records–and this challenge still doesn’t have an efficient solution, the professor says. There is a lot to do in terms of improving processes around patient care and organizing hospitals’ work, he believes.
  • Artificial Intelligence (AI) / Internet of Things (IoT) for medical devices and wearables. For instance, monitoring patients’ health to detect serious illnesses (like deep vein thrombosis) that can be treated if diagnosed in a timely manner. ‘AI can monitor hundreds of health parameters, 24/7, it doesn’t need a coffee break. It is efficient, and inexpensive, and can save lives as it is able to detect symptoms before doctors and nurses notice them.’
  • BioTech. Here, Dr. Epler says, humanity can create drugs that are on a more of a molecular level to tackle the most complex diseases, like cancer. Nevertheless, he adds, these advancements require several years and billions of dollars of investments, not to mention specialized equipment and powerful R&D teams.

Digitalization to Transform Operations

Covid-19 and drug price uncertainty has helped transform drug development lifecycles, says Michael Buchanio, Senior Principal, Healthcare M&A, at West Monroe Partners. ‘Due to the pandemic disruptions across the spectrum, especially around limited patient encounters, the routine and non-urgent care visits have dramatically decreased.’

According to Buchanio, the following factors are crucial to drive digital transformation and innovations in the US healthcare industry.

  • Limited clinical resources. Lack of care and management personnel in outpatient settings, and a ‘general reluctance for travel’ has caused many ongoing research projects to be delayed. Some cases were even stopped due to patient recruitment issues.
  • Increased price scrutiny. US drug prices are nearly 4 times higher than in similarly situated countries. In Japan, our panelist says, the average drug price is more than 6 times less than US prices. Both parties support drug pricing policies, ignited by cases of rapid price surges to generics and brands, like the infamous 5300% rise by Martin Shkreli’s pharmaceutical company.
  • Drug development costs rise, timelines stagnate. Buchanio says, the average cost to bring a drug to market is estimated at $2.6B high, with $1–1.3B being the mean investment. Timelines, meanwhile, remain flat, as a new drug or a vaccine takes 7-8 years to get FDA approval (Phases I to III).

Solutions to these issues can be found via the end-to-end adoption of digital technologies. They are already improving the patient experience and compliance while reducing costs and shortening time to market. For instance, Buchanio says, secure video conferencing and e-signatures tackle the issue of informed consent as well as prescreening and remote monitoring. Clinical trials are thus becoming decentralized.

‘Do I think that such technologies will be fully adopted in the near future? Probably not. But we see all the technology players making huge investments in this space. And we’re seeing a lot of pharmaceutical companies doing their trials with this decentralized approach,’ adds Buchanio.

Other Insights

See More
DACH M&A Trends
M&A

DACH M&A Trends Report H1 2021

Brought to you by the M&A Community in association with Mergermarket.  Real estate, pharma, industrial and chemicals and technology...

See More
latam mna trends
M&A

LatAm M&A Trends Report H1 2021

Brought to you by the M&A Community in association with Mergermarket.  Led by the financial services sector and big deals in energy...

See More
Iberia M&A trends
M&A

Iberia M&A Trends Report H1 2021

Brought to you by the M&A Community in association with Mergermarket.  Rapidly expanding opportunities in energy, especially...

See More
M&A

China & Hong Kong M&A Trends Report H1 2021

Brought to you by the M&A Community in association with Mergermarket.  As both economies bounce back from Covid-19, infrastructure and...

See More
USA
digital-USD
Digital currency

Webinar: Are Digital Currencies Disrupting Global Markets? Risks, Opportunities, And Outlook

Cryptocurrencies, once viewed as the province of nerds and dodgy financial transactions, are now becoming mainstream. More countries around the...

See More
Mexico
IPO
M&A

M&A Latam, Facts, Trends, & Insights For 2021

M&A activity is fast recovering from the impact of Covid-19 all round the world. This is especially evident in Latin America (LATAM) where,...

See More
USA
digital assets
Digital assets

Acquisition and Integration of Digital Assets

In the last 15 years more than 52% of US listed companies have disappeared, and while the average life of such a company in 1955 was 61 years,...

See More
Portugal
green energy
Energy

The Ins and Outs of Becoming a Player in Portugal’s Green Energy Market

Portugal has seen a rapid expansion of investment in renewable energy in recent years, especially in solar PV. There has been considerable...

See More
Brazil
spain
Infrastructure

Infrastructure Insiders Discuss Opportunities and Bottlenecks

Cleverson Aroeira (BNDES), Venilton Tadini (ABDIB), Elias de Souza (Deloitte) and Thiago Costa Monteiro Caldeira (PPI) untangled the sector and...

See More
Russia
Agriculture

Will Smart Farming Make Agriculture More Sustainable? An Interview with the Founder of iFarm

Digitization in agriculture can help use resources efficiently and rationally, allowing farmers to get the most out of the outcome.

See More
Russia
iFarm - vertical farm in Finland
Agriculture

Innovations in Agriculture: A Lucrative Field for Investors

Investor interest in vertical farming surged in 2020, reaching $929M in the US alone.

See More
Russia
M&A Agriculture
Agriculture

What’s Happening in the Agribusiness in Russia? An M&A Point of View

Crop production seems to be the most lucrative segment in Russian agriculture as the demand is substantially higher than the supply.

See More
USA
Health Tech M&A
Healthcare

Telemedicine is Changing the Healthcare Landscape: Expert Outlook 2021

With several new coronavirus strains circulating, it is hardly likely that the healthcare industry will soon escape from this period of...

See More
USA
M&A AI Tech
Tech

M&As in the AI Market: Tech and Deals Explained

The artificial intelligence (AI) industry survived its ‘winter’, in terms of limited hardware capacities, some time ago. Now, this sector seems...

See More
USA
Bruce Molloy
Tech

AI Industry: What Any Business Leader Should Know

Business leaders can understand what AI can do in straightforward ways, including the opportunities it creates, the problems it solves, and the...

See More
Brazil
Sao Paulo, Brazil
M&A

Experts Show Optimism for the M&A Market in Brazil in 2021

Economic recovery in a Brazilian context will involve greater liquidity and an enormous structural change.

See More
Brazil
The National Congress of Brazil
M&A

The LGPD to Attract More Foreign Investment to Brazil

With the LGPD, the business environment will have more clarity about the regulations to be made a clearer perspective for foreign investors.

See More
New Normal
M&A

M&A: Getting Used to the ‘New Normal’ 

Political and geopolitical tensions worldwide may also hint at the events we might see in the nearest future. What are the main currents in the...

See More
Portugal
Oporto, Portugal
M&A

M&A in the North of Portugal: Tough Situation, Plenty of Opportunities

The outlook of the mergers and acquisitions landscape in the north of Portugal.

See More
Reva Goujon
M&A

‘Strategic Scenario Planning’: Reva Goujon — about resilient M&A Approach, US-China Rivalry, and Cyber Influence Ops 

How to design smart and resilient M&A strategies amidst global uncertainties?

See More
Russia
moscow city
M&A

M&A in Russia: Negative Trends with a Silver Lining?

Despite several periods of turbulence, and downturns, the Russian M&A market ‘is still alive’.

See More
USA
Crossroads
M&A

Global Business Climate, Geopolitics, and M&A: Where we are at now 

Everyone, from small firms to large corporations, has to adapt to the new realities and find new ways to stay afloat.

See More
USA
Tech

‘AI Hype’ and M&A: Artificial Intelligence Strategies and Putting a Value on a Deal

How AI technologies can create value for different industries, and what to consider during any AI-related M&A transaction.

See More
Ignacio Tornero
M&A

China Goes Overseas: The Successes and Challenges of PRC in Latin America. An Interview with Ignacio Tornero

Digging deeper into the Chinese expansion in Latin America.

See More
USA
Tech

Tech, M&As and their Future: Reality and Expectations

From the valuation of AI assets to IoT, blockchain, and ESG (Environmental and Social Governance) in business.

See More
Portugal
Porto, Portugal
Legal

Legal Frameworks for Turbulent Times: Cases of Distressed Investments in Portugal

Are there ways to prevent the wave of insolvencies expected in 2021?

See More
USA
M&A

Geopolitics and M&A: Power Play in the Turbulent World. An Interview with Klisman Murati

How do geopolitics define the long-term strategies of states, and impact the economic actors?

See More
Portugal
M&A

Distressed Investments in Portugal: An Economic and Legal Outlook

The number of insolvencies in Portugal is rising and businesses are facing uncertainty in terms of future financing.

See More
USA
Hong Kong harbor
M&A

China’s Gordian Knot of Geopolitics: Regional Expansion or Global Ambitions?

Though Beijing is being careful with international politics, in an economic scene it is more active.

See More
Israel
Healthcare

China and Russia: Behind the Scenes of Healthcare and Biotech M&As

How is the M&A landscape in the healthcare industry changing?

See More
USA
Investment

The US vs. China: How their Geopolitical Game is Affecting M&As

Beijing remains cautious in terms of restrictive measures against the US in response.

See More
Israel
Healthcare

Changing Landscapes in Chinese, Russian, and Israeli Healthcare Investments 

The healthcare and life sciences branches seem to be struggling with the new challenges.

See More
Australia
M&A

Four Human Capital Factors to Consider during an M&A Deal

Without the proper management of human resources, the majority of M&A deals are bound to fail.

See More
Australia
M&A

Extracting Commercial Benefit from Data: Lessons for M&As

Data can be applied and bring value at various stages of the M&A process.

See More
Brazil
Legal

LGPD in Brazil: How the New Data Protection Law is impacting Businesses and Deals

Here are some useful hints and recommendations by experts in the field

See More
China
Investment

M&A Regulatory Updates in China and Abroad 

How can tightening regulations impact the M&A situation in the Asia-Pacific region?

See More
M&A

Global M&A: Is a Recovery in Sight?

The full impact of the coronavirus crisis has manifested itself in Q2 2020. Here’s a brief overview of the global M&A situation in Q&A.

See More
China
M&A

Trends That Are Defining Cross-Border M&A in China

The global M&A market is showing a strong decline: it has more than halved to $0.9T in the first half of 2020.

See More
USA
Inner city investment in the USA
Investment

Three Cases to Describe the Progression of Impact Investing 

Investors wanting more societal changes are fueling growth in impact investing, allocating capital to assets that push positive changes forward.

See More
USA
Investment

Paradigm Shift in Impact Investing: Trends to Influence Businesses in a Post-Pandemic World

While the world is living through turbulent times, businesses and investors cannot stand aside unaffected. To dive deep into the issues of...

See More
China
Energy

Global Energy Investments and M&A: A Quick Guide

The chaos this year on the oil market seems to have echoed into other energy sectors, leaving investors in a state of uncertainty. However, this...

See More
China
Energy

Investment Opportunities and Risks in the Global Energy Industry

2020 looks like being the biggest black swan event since WWII. The global pandemic has affected the mentality of investors all over the world....

See More
China
legal service
Legal

The Role of Legal Service Providers in Cross-Border M&A

In recent years, an increasing number of Chinese companies are seeking international expansion in response to the nation’s “Go Global” campaign....

See More
China
business mna
M&A

How to improve bid success rate in cross-border M&A

Initiated by iDeals and co-organized by several key players in the cross-border M&A industry such as KPMG, Eurasian, and GORG, the China-EU...

See More
China
mna community
Investment

M&A Community In-depth Interview: The Three Key Questions in China-EU M&A

Recently, iDeals hosted the M&A Community: China-EU Cross-border Best Practice Sharing event in Shanghai.

Speakers of this event

See More
USA

Dr. Gary Epler

Partner at CDI Global Healthcare
See More
USA

Michael Buchanio

Senior Principal - Healthcare M&A at West Monroe Partners
See More
USA

Troy Crabtree

Founder of Navita (TeleMate)

Past Events

Online
Learn more arrow right icon
Colombia
September 29

Energy Investment Projections In Latin America

Online
Learn more arrow right icon
Brazil
September 29

Energy investment projections in Brazil

Get In Touch

Our team is happy to answer your questions. Fill out this form and we will get in touch with you.